Mesuximide

From Wikipedia, the free encyclopedia

Mesuximide
Systematic (IUPAC) name
1,3-dimethyl-3-phenyl-pyrrolidine-2,5-dione
Identifiers
CAS number 77-41-8
ATC code N03AD03
PubChem 6476
Chemical data
Formula C12H13NO2 
Mol. mass 203.237 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism Hepatic (demethylation and glucuronidation)
Half life 1.4–2.6 hours (mesuximide)
28–38 hours (active metabolite)
Excretion Renal
Therapeutic considerations
Pregnancy cat.

C(US)

Legal status

-only(US)

Routes Oral

Mesuximide (or methsuximide) is an anticonvulsant medication. It is sold by Pfizer under the tradenames Petinutin (Switzerland)[1] and Celontin (United States).[2]

[edit] References

  1. ^ Pfizer AG (2005). Petinutin (Mésuximide) (French). Official Pfizer AG Website. Retrieved on August 21, 2006.
  2. ^ Pfizer Inc. (2008). Celontin (methsuximide capsules, USP). Official Pfizer Inc. Website. Retrieved on June 10, 2008.
Languages